Literature DB >> 21946533

Fasting serum apolipoprotein B-48 can be a marker of postprandial hyperlipidemia.

Daisaku Masuda1, Naohiko Sakai, Taizo Sugimoto, Rika Kitazume-Taneike, Taiji Yamashita, Ryota Kawase, Hajime Nakaoka, Miwako Inagaki, Kazuhiro Nakatani, Miyako Yuasa-Kawase, Kazumi Tsubakio-Yamamoto, Tohru Ohama, Yumiko Nakagawa-Toyama, Makoto Nishida, Masato Ishigami, Yoshiro Masuda, Akifumi Matsuyama, Issei Komuro, Shizuya Yamashita.   

Abstract

AIM: Postprandial hyperlipidemia (PH) is thought to be caused by the impaired postprandial metabolism of triglycerides (TG)-rich lipoproteins in both endogenous and exogenous pathways; however, there is no consensus. It is difficult to estimate the presence of PH without performing a time-consuming oral fat loading (OFL) test, so postprandial lipoprotein metabolism was analyzed by measuring the postprandial levels of apolipoprotein (apo) B-48 and apo B-100, and the correlation between postprandial TG increase and fasting apoB-48 levels was assessed to establish a good marker of PH without performing an OFL test.
METHODS: Ten male normolipidemic subjects were loaded with a high-fat (HF, 1045 kcal) or standard (ST, 566 kcal) meal, and the lipids, apolipoproteins and lipoprotein profiles were analyzed after each meal.
RESULTS: TG, apo B-48, remnant-like particles (RLP)-cholesterol and RLP-TG levels were increased and their levels were significantly higher after intake of the HF meal than the ST meal; however, there was no postprandial increase in apo B-100 and LDL-C levels. Postprandial increases in TG levels of CM, VLDL, LDL and HDL were significantly higher after intake of the HF meal than the ST meal. Fasting apo B-48 levels were strongly correlated with the incremental area under the curve of TG after intake of the HF meal, but not the ST meal.
CONCLUSION: Postprandial TG increase was mainly due to increased CM and CM-R, but not VLDL. Measurement of fasting serum apo B-48 may be a simple and useful method for assessment of the existence of PH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21946533     DOI: 10.5551/jat.10470

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  16 in total

1.  Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors.

Authors:  Jixin Zhong; Andrei Maiseyeu; Sanjay Rajagopalan
Journal:  Clin Lipidol       Date:  2015

2.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

Review 3.  Insights from human congenital disorders of intestinal lipid metabolism.

Authors:  Emile Levy
Journal:  J Lipid Res       Date:  2014-11-11       Impact factor: 5.922

4.  The relationship between the postprandial lipemic response and lipid composition in persons with spinal cord injury.

Authors:  Racine R Emmons; Christopher M Cirnigliaro; Steven C Kirshblum; William A Bauman
Journal:  J Spinal Cord Med       Date:  2014-06-24       Impact factor: 1.985

5.  Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease.

Authors:  Akihiro Nakamura; Yuto Monma; Shoko Kajitani; Kazuki Noda; Sota Nakajima; Hideaki Endo; Tohru Takahashi; Eiji Nozaki
Journal:  Heart Vessels       Date:  2015-10-06       Impact factor: 2.037

6.  Effect of Glycemic Control on Chylomicron Metabolism and Correlation between Postprandial Metabolism of Plasma Glucose and Chylomicron in Patients with Type 2 Diabetes Treated with Basal-bolus Insulin Therapy with or without Vildagliptin.

Authors:  Fumitaka Okajima; Naoya Emoto; Katsuhito Kato; Hitoshi Sugihara
Journal:  J Atheroscler Thromb       Date:  2016-07-08       Impact factor: 4.928

7.  Oral Fat Tolerance Test for Sitosterolemia and Familial Hypercholesterolemia: A Study Protocol.

Authors:  Akihiro Nomura; Hayato Tada; Atsushi Nohara; Masa-Aki Kawashiri; Masakazu Yamagishi
Journal:  J Atheroscler Thromb       Date:  2018-01-20       Impact factor: 4.928

8.  Phosphorus supplement alters postprandial lipemia of healthy male subjects: a pilot cross-over trial.

Authors:  Jana Hazim; Sani Hlais; Hala Ghattas; Dareen Shatila; Maya Bassil; Omar Obeid
Journal:  Lipids Health Dis       Date:  2014-07-08       Impact factor: 3.876

Review 9.  Postprandial Hyperlipidemia and Remnant Lipoproteins.

Authors:  Daisaku Masuda; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2016-11-08       Impact factor: 4.928

10.  ApoB48 as an Efficient Regulator of Intestinal Lipid Transport.

Authors:  Chunmin C Lo; Karen T Coschigano
Journal:  Front Physiol       Date:  2020-07-08       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.